1422365-93-2

1422365-93-2 structure

Name: IM156
Chemical Name: N-{N-[4-(Trifluoromethoxy)phenyl]carbamimidoyl}-1-pyrrolidinecarboximidamide
CAS Number: 1422365-93-2
Molecular Formula: C₁₃H₁₆F₃N₅O
Molecular Weight: 315.29
Catalog: Research Areas Cancer
Create Date: 2021-01-12 15:11:39
Modify Date: 2024-01-21 12:02:51
Lixumistat (IM156) is a novel biguanide mitochondrial protein complex 1 inhibitor of oxidative phosphorylation (OXPHOS) with anti-tumor activity. Lixumistat regulates OXPHOS to attenuate mitochondrial metabolic reprogramming and inhibit lung fibrosis. Lixumistat also suppresses B-cell activation to alleviate systemic lupus erythematosus[1][5].

Name	N-{N-[4-(Trifluoromethoxy)phenyl]carbamimidoyl}-1-pyrrolidinecarboximidamide
Synonyms	N-{N-[4-(Trifluoromethoxy)phenyl]carbamimidoyl}-1-pyrrolidinecarboximidamide 1-Pyrrolidinecarboximidamide, N-[imino[[4-(trifluoromethoxy)phenyl]amino]methyl]-

Description	Lixumistat (IM156) is a novel biguanide mitochondrial protein complex 1 inhibitor of oxidative phosphorylation (OXPHOS) with anti-tumor activity. Lixumistat regulates OXPHOS to attenuate mitochondrial metabolic reprogramming and inhibit lung fibrosis. Lixumistat also suppresses B-cell activation to alleviate systemic lupus erythematosus[1][5].
Related Catalog	Research Areas >> Cancer
Target	oxidative phosphorylation (OXPHOS)[1]
References	[1]. Willette RN, et al. Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis. J Pharmacol Exp Ther. 2021 Nov;379(3):290-300. [2]. Shim JS, Kim EJ, Lee LE, Kim JY, Cho Y, Kim H, Kim J, Jang SH, Son J, Cheong JH, Kim A, Lim BJ, Ha SJ, Song JJ, Kim BS. The oxidative phosphorylation inhibitor IM156 suppresses B-cell activation by regulating mitochondrial membrane potential and contributes to the mitigation of systemic lupus erythematosus. Kidney Int. 2023 Feb;103(2):343-356.

Hazard Codes	Xn